1. Bahadori M, Ghavidel F, Mohammadzadeh S, Ravangard R. The
effects of an interventional program based on self‑care model on
health‑related quality of life outcomes in hemodialysis patients.
J Educ Health Promot 2014;3:110.
2. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO.
The prevalence and phenotypic features of polycystic ovary
syndrome: A systematic review and meta‑analysis. Hum Reprod
2016;31:2841‑55.
3. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F,
Faghihzadeh S. Health‑related quality of life and its relationship
with clinical symptoms among Iranian patients with polycystic
ovarian syndrome. Iran J Reprod Med 2013;11:371‑8.
4. Podfigurna‑Stopa A, Luisi S, Regini C, Katulski K, Centini G,
Meczekalski B, et al. Mood disorders and quality of life in
polycystic ovary syndrome. Gynecol Endocrinol 2015;31:431‑4.
5. Spritzer PM, Marchesan LB, Santos BR, Cureau FV, Oppermann K,
Reis RM, et al. Prevalence and characteristics of polycystic ovary
syndrome in Brazilian women: Protocol for a nation‑wide
case‑control study. BMJ Open 2019;9:e029191.
6. Mazloomy Mahmoodabad S, Ardjmandi M, Farajkhoda T,
Karimi Zarchi M, Fallah zadeh H. To evaluate health‑related
quality of life in women with polycystic ovary syndrome in Yazd,
2014. TB. Tolooebehdasht 2016;14:236‑46.
7. PanziniRG, Paz Mosqueiro B, ZimpelRR, Bandeira NS, Rocha DR,
Fleck MP. Quality‑of‑life and spirituality. Int Rev Psychiatry
2017;9:1‑11.
8. WHOQOL Group. Development of the World Health Organization
WHOQOL‑BREF quality of life assessment. Psychol Med
2012;28:551‑8.
9. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey
of chronic pain in Europe: Prevalence, impact on daily life, and
treatment. Eur J Pain 2006;10(4):287‑333.
10. Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M,
et al. Prevalence and implications of anxiety in polycystic ovary
syndrome: Results of an internet‑based survey in Germany. Hum
Reprod 2009;24:1446‑51.
11. Månsson M, Holte J, Landin‑Wilhelmsen K, Dahlgren E,
Johansson A, Landén M. Women with polycystic ovary
syndrome are often depressed or anxious‑a case control study.
Psychoneuroendocrinology 2008;33:1132‑8.
12. Shahbazi S, Kafi M, Seyed M, Fallahi M, Shafti V. Self‑efficacy,
marital adjustment, and quality of life in women with polycystic
ovary syndrome. J Holistic Nurs Midwifery Spring 2017;27:87‑93.
13. Zangeneh FZ, Naghizadeh MM, Bagheri M. Comparing life style
of patients with polycystic ovary syndrome and normal women.
Tehran Univ Med J 2018;76:58‑66.
14. Kheirabadi G, Bagherian R, Nemati KD, Marassi M,
Gholamrezaei A. The effect of coping strategies training on
symptom severity, quality of life and symptomatic symptoms.
J Isfahan Med Schl 2010;28:195‑202.
15. Talepasand S, Mahfar F. Relationship Between Defense
Mechanisms and the Quality of Life in Women With Breast
Cancer, Int J Cancer Manag. 2018;11(1):e11116. doi: 10.5812/
ijcm.11116.
16. Vollman MW, Lamontagne LL, Hepworth JT. Coping and
depressive symptoms in adults living with heart failure.
J Cardiovasc Nurs 2007;22:125‑30.
17. Rzońca E, Iwanowicz‑Palus G, Bień A, Wdowiak A, Szymański R,
Chołubek G. Generalized self‑efficacy, dispositional optimism,
and illness acceptance in women with polycystic ovary syndrome.
Int J Environ Res Public Health 2018;15(11):2484.
18. Rahimi E, Abyar Z, Homam Zakeri langroudi A, Zamani N.
Comparison of general health, mental health and coping strategies
among patients with diabetes type 1, 2 and patients with multiple
sclerosis. Hrjbaq 2017;2:33‑41.
19. Nedaei A, Paghoosh A, Sadeghi‑Hosnijeh A. Relationship
between coping strategies and quality of life: mediating role of
cognitive emotion regulation skills. J Clin Psychol 2016;8:35‑48.
20. KlineRB. Principles and Practice of Structural Equation Modeling.
4th ed. New York: Guilford Press; 2015. p. 11‑5.
21. Usefi AR, Ghassemi GH, Sarrafzadegan N, Malek S, Baghaei A,
Rabiei K. Psychometric properties of the WHOQOL‑BREF in an
Iranian Adult sample‑ community Mental Health J 2010;46:139‑47.
22. Samie Barsari S. Psychometric Properties of Lazarus‑Folkman
Coping Strategies Questionnaire (WOCQ) and its Relationship
with Anxiety and Self‑efficacy Coping with Problems, MSc Thesis;
2014.
23. Cohen J. Statistical Power Analysis for the Behavioral Sciences.
2nd ed. Hillsdale: Earlbaum; 1988. Available from: http://www.
utstat.toronto.edu/~brunner/oldclass/378f16/readings/
CohenPower.pdf. [Last accessed on 2020 Oct 14].
24. Ebrahimi F, Enjezab B. Quality of life, general health status
and related factors in women of polycystic ovary syndrome in
Yazd (IRAN) 2014, Int J Med Res Health Sci 2016;5:7S, 91‑7.
25. Mansour S, Marzeeyeh MM. Comparing resiliency, social
competence and defense mechanism styles in women with
and without ovarian cysts. J Thought Behav Clin Psychol
2016;10(39):77‑86.
26. Benson S, Hahn S, Tan S, Janssen OE, Schedlowski M,
Elsenbruch S. Maladaptive coping with illness in women with
polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs
2010;39:37‑45.
27. Sundararaman PG, Shweta, Sridhar GR. Psychosocial aspects of
women with polycystic ovary syndrome from South India. Assoc
Physicians India 2008;56:945‑8.
28. Kafaei‑Atrian M, Mohebbi‑Dehnavi Z, Sayadi L ,
Asghari‑Jafarabadi M, Karimian‑Taheri Z, Afshar M. The
relationship between the duration of menstrual bleeding and
obesity‑related anthropometric indices in students. J Educ Health
Promot 2019;8:81.
29. Açmaz G, Albayrak E, Acmaz B, Başer M, Soyak M, Zararsız G,
et al. Level of anxiety, depression, self‑esteem, social anxiety, and quality of life among the women with polycystic ovary syndrome.
ScientificWorldJournal 2013;2013:1‑7.
30. TehraniHG, AllahdadianM, ZarreF, RanjbarH, AllahdadianF. Effect
of green tea on metabolic and hormonal aspect of polycystic ovarian
syndrome in overweight and obese women suffering from polycystic
ovarian syndrome: A clinical trial. J Educ Health Promot 2017;6:36.
31. Scaruffi E, Gambineri A, Cattaneo S, Turra J, Vettor R, Mioni R.
Personality and psychiatric disorders in women affected by
polycystic ovary syndrome. Front Endocrinol (Lausanne)
2014;5:185.